版本:
中国

BRIEF-CTI Biopharma announces pricing of underwritten public offering of $45 mln of convertible preferred stock

June 6 CTI Biopharma Corp

* CTI Biopharma prices underwritten public offering of $45 million of convertible preferred stock

* CTI Biopharma-prices underwritten public offering of 22,500 shares of series n-3 preferred stock, offered at price to public of $2,000 per share of series n-3 preferred stock Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐